Tag - TRPX

Developments

Therapix reports positive topline results from Phase 2a obstructive sleep apnea trial

Therapix Biosciences (NASDAQ:TRPX) reported topline results from its Phase 2a clinical study of THX-110 for the treatment of obstructive sleep apnea (OSA). THX-110 is a combination of dronabinol, or synthetic THC, and...

November 13, 2019

Developments

Therapix’s CannAmide approved by Health Canada

Therapix Biosciences (NASDAQ:TRPX) reported that Health Canada issued a product license for CannAmide as an anti-inflammatory, and for relief of chronic pain. CannAmide is an immediate release formulation of the...

July 31, 2019

Tag - TRPX

Therapix reports positive topline results from Phase 2a obstructive sleep apnea trial

Therapix’s CannAmide approved by Health Canada

General

More